Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...

As scientific disinformation skyrockets, the Biotechnology Innovation Organization (BIO)—the world’s largest biotech trade association—is aiming to set the record straight on vaccines, rolling out a ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cabaletta Bio ( (CABA)) has shared an ...

In this issue of BioTechniques, we present the development of a BRET-based senor for the detection and quantification of interactions involving regulatory subunit B56α, an assay for monitoring ...

Shares of ImmunityBio (NASDAQ:IBRX) traded higher on Wednesday after the immunotherapy developer disclosed early-stage trial results for its natural killer cell therapy candidate in patients with a ...

Clear data visuals are among the most powerful tools a foundation or nonprofit can use to communicate progress, inform decisions, and build trust with stakeholders. A successful chart shows at a ...

LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Verdiva Bio Limited (“Verdiva” or “the Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and ...

(RTTNews) - Arcutis Biotherapeutics, Inc. (ARQT), on Friday announced it will present five poster presentations at the 2025 Revolutionizing Atopic Dermatitis or RAD Conference, including new long-term ...

Living 150 years could not just be possible – it could soon be inevitable, according to human biologist and biohacker Gary Brecka. "If you're alive in five years, I believe it will be your choice ...

What makes one presentation unforgettable while another fades into obscurity? The answer often lies in the art of storytelling—and in today’s data-driven world, this art has taken on a new form.

Rani Therapeutics announced positive preclinical data for RT-114 and semaglutide, advancing toward Phase 1 obesity trials in mid-2025. Rani Therapeutics Holdings, Inc. has announced preclinical data ...

The Los Angeles Angels are witnessing things never before seen in franchise history during this already very special start to the season. Catcher Logan O'Hoppe hit a home run in four straight games ...